Literature DB >> 28663363

First and recurrent ischaemic heart disease events continue to decline in New Zealand, 2005-2015.

Corina Grey1, Rod Jackson1, Susan Wells1, Billy Wu1, Katrina Poppe1, Harvey White2, Wing Cheuk Chan3, Andrew J Kerr1,3.   

Abstract

OBJECTIVES: To examine recent trends in first and recurrent ischaemic heart disease (IHD) deaths and hospitalisations.
METHODS: Using anonymous patient-linkage of routinely collected data, all New Zealanders aged 35-84 years who experienced an International Statistical Classification of Diseases and Related Health Problems I(CD)-coded IHD hospitalisation and/or IHD death between 1 January 2005 and 31 December 2015 were identified. A 10-year look-back period was used to differentiate those experiencing first from recurrent events. Age-standardised hospitalisation and mortality rates were calculated for each calendar year and trends compared by sex and age.
RESULTS: 160 109 people experienced at least one IHD event (259 678 hospitalisations and 35 548 deaths) over the 11-year study period, and there was a steady decline in numbers (from almost 24 000 in 2005 to just over 16 000 in 2015) and in age-standardised rates each year. With the exception of deaths in younger (35-64 years) women with prior IHD, there was a significant decline in IHD events in men and women of all ages, with and without a history of IHD. The decline in IHD mortality was greater for those experiencing a first rather than recurrent IHD event (3.8%-5.2% vs 0%-3.7% annually on average). In contrast, the decline in IHD hospitalisations was greater for those experiencing a recurrent compared with a first IHD event (5.6%-7.3% vs 3.2%-5.7% annually on average).
CONCLUSIONS: The substantial decline in IHD hospitalisations and mortality observed in New Zealanders with and without prior IHD between 2005 and 2015 suggests that primary and secondary prevention efforts have been effective in reducing the occurrence of IHD events. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Acute coronary syndromes; Acute myocardial infarction; Coronary artery disease; Epidemiology

Mesh:

Year:  2017        PMID: 28663363     DOI: 10.1136/heartjnl-2017-311613

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  4 in total

1.  Comparative trends in coronary heart disease subgroup hospitalisation rates in England and Australia.

Authors:  Lee Nedkoff; Raphael Goldacre; Melanie Greenland; Michael J Goldacre; Derrick Lopez; Nick Hall; Matthew Knuiman; Michael Hobbs; Frank M Sanfilippo; F Lucy Wright
Journal:  Heart       Date:  2019-04-04       Impact factor: 5.994

2.  World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions.

Authors: 
Journal:  Lancet Glob Health       Date:  2019-09-02       Impact factor: 26.763

3.  Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014.

Authors:  Karolina Szummer; Lars Wallentin; Lars Lindhagen; Joakim Alfredsson; David Erlinge; Claes Held; Stefan James; Thomas Kellerth; Bertil Lindahl; Annica Ravn-Fischer; Erik Rydberg; Troels Yndigegn; Tomas Jernberg
Journal:  Eur Heart J       Date:  2017-11-01       Impact factor: 29.983

4.  Performance of a Framingham cardiovascular risk model among Indians and Europeans in New Zealand and the role of body mass index and social deprivation.

Authors:  Kjersti Stormark Rabanal; Haakon Eduard Meyer; Romana Pylypchuk; Suneela Mehta; Randi Marie Selmer; Rodney T Jackson
Journal:  Open Heart       Date:  2018-07-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.